HealthEquity, Inc. (HQY) vs Ionis Pharmaceuticals, Inc. (IONS)
A side-by-side comparison of HealthEquity, Inc. and Ionis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HQY
HealthEquity, Inc.
$91.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IONS
Ionis Pharmaceuticals, Inc.
$44.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HQY vs IONS
growth of $100 · dividends reinvested · last 10yHQY +141.4% (+9.2%/yr)IONS +22.0% (+2.0%/yr)HQY compounded faster over this window
HQY IONS
HQY vs IONS: by the numbers
- •HQY is the larger company ($7.61B vs $7.31B market cap).
- •HQY is profitable (17.36% net margin) while IONS runs a net loss (-64.64%).
- •HQY grew revenue faster over the past five years (12.96% vs 4.91% CAGR).
Metrics side by side
Valuation
| Metric | HQY | IONS |
|---|---|---|
| P/E ratio | 32.87 | N/A |
| Forward P/E | 19.27 | N/A |
| PEG ratio | 0.40 | N/A |
| P/S ratio | 5.59 | 8.37 |
| P/B ratio | 3.82 | 16.63 |
| EV / EBITDA | 17.31 | 2.21 |
| FCF yield | 6.20% | N/A |
Profitability
| Metric | HQY | IONS |
|---|---|---|
| Gross margin | 75.21% | 98.16% |
| Operating margin | 25.61% | -40.47% |
| Net margin | 17.36% | -64.64% |
| ROE | 11.88% | -128.44% |
| ROIC | 8.55% | -20.37% |
Growth (annualized)
| Metric | HQY | IONS |
|---|---|---|
| Revenue CAGR (5Y) | 12.96% | 4.91% |
| EPS CAGR (5Y) | 83.56% | N/A |
| FCF CAGR (5Y) | 36.72% | N/A |
| Total return CAGR (5Y) | 7.00% | 5.82% |
Frequently asked
- Which has grown faster, HQY or IONS?
- Over the past five years, HQY grew revenue faster — HQY at a 12.96% CAGR versus IONS at 4.91%.
- Is HQY or IONS more profitable?
- HQY runs the higher net margin — HQY at 17.36% versus IONS at -64.64%.
- How have HQY and IONS total returns compared?
- Over the past 10 years, HQY delivered 9.16% and IONS delivered 1.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
HealthEquity P/E ratioHealthEquity ROEIonis Pharmaceuticals ROEHealthEquity operating marginIonis Pharmaceuticals operating marginHealthEquity revenue growthIonis Pharmaceuticals revenue growthHealthEquity free cash flowIonis Pharmaceuticals free cash flow
HealthEquity & Ionis Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.